NEWPORT BEACH, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in the 7th Annual Truist Securities Life Sciences Summit.
Event: | 7th Annual Truist Securities Life Sciences Summit |
Format: | Fireside Chat & 1x1 Meetings |
Date: | Wednesday, May 5, 2021 |
Time: | 3:30pm – 4:10pm ET |
Location: | Evolus Live Fireside Chat |
An audio webcast of Evolus’ fireside chat will be available on the investor relations section of Evolus’ website at investors.evolus.com . Replay of the webcast will be available for 90 days after the date of the presentation.
About Evolus, Inc.
Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau ® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure ™ technology. Jeuveau ® is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at: www.evolus.com .
Jeuveau ® is a registered trademark of Evolus, Inc.
Hi-Pure ™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
Investor Contact
The Ruth Group
Christine Petraglia
Senior Vice President
Tel: 917-633-8980
Email: cpetraglia@theruthgroup.com